Is Apple eyeing healthcare AI? Big money seems to think so

International investment firm Morgan Stanley believes odds are strong that Apple will become a major player in healthcare AI, according to an article published Sept. 16 in AppleInsider.

“Morgan Stanley reckons the value-based model could be a monetization method for Apple’s own efforts,” reports AppleInsider writer Malcolm Owen, working from a note to investors received by AppleInsider about Morgan Stanley’s recent Global Healthcare Conference.

Apple is “rapidly expanding the amount of data consumers can aggregate into [its] Health app,” the note advises. “This creates a greenfield opportunity for Apple to deploy its advanced silicon and AI capabilities across these data sets.”

Read the whole thing:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”